483 Aurolife Pharma Feb 2020

483 Aurolife Pharma Feb 2020

Jogy George FDA, Lata Mathew FDA, Emmanuel Ramos FDA, Unnee Ranjan FDA$119.00 - Available Now

FDA investigators audited the Aurolife Pharma - Dayton, NJ, United States facility and issued inspectional observations (via FDA 483) on 12 Feb 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Feb 2020
  • Location: Dayton, United States
  • FEI: 3005796917
Add To Cart